G.ChakrabartiR.RowlandE
The glucagon-like peptide-1 (GLP-1) receptor agonist, exenatide, inhibits small intestinal motility, flow, transit and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomised controlled trial
After PS matching, no differences were observed in age, sex, height, weight, BMI, eGFR, smoking status, alcohol consumption, or the number of health screening examinations among the three groups
A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms
[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Drucker D.J., Philippe J., Mojsov S., Chick W.L., Habener J.F